Last updated: June 2, 2026
EMTRIVA (emtricitabine) Supplier Landscape: API, Finished Dosage, and Key Contract Manufacturer Footprints
EMTRIVA (emtricitabine) is supplied to the U.S. market as a finished drug product, with API and finished-dose sourcing handled through established global pharmaceutical supply chains. The primary commercial manufacturer for EMTRIVA in the U.S. is Gilead Sciences, Inc.; distribution of finished product is carried through major U.S. wholesalers and Gilead’s logistics network.
What’s missing: You asked for “suppliers,” but there are multiple supplier categories (API manufacturer, finished-dose manufacturer, labeler/distributor, and alternate sources across dosage strengths and markets). The request does not specify which category and does not provide the jurisdiction, dosage form, or whether you mean API, finished product, or both. Under the operating constraints, a complete and accurate supplier map cannot be produced from the information provided.
Who supplies EMTRIVA finished drug product in the U.S.?
Answer: The finished product “labeler” and primary commercial source for EMTRIVA in the U.S. is Gilead Sciences, Inc. (manufacturer/distributor for the branded product supply chain).
What are the typical U.S. distribution channels for EMTRIVA?
- Primary U.S. wholesalers (pharmacy distribution network)
- Gilead-managed logistics supporting contracted downstream channels
Which companies manufacture emtricitabine API for EMTRIVA?
Answer: Not determinable to a complete, accurate list from the provided prompt alone, because API suppliers vary by program year, manufacturing site changes, and availability across regulatory filings.
Why API supplier lists are hard to pin down
- API supply can shift by site qualification, capacity, and regulatory updates
- API manufacturers are not consistently identifiable from brand-level product descriptions alone; they typically require DMF site mapping and/or Orange Book manufacturing detail by strength, dosage form, and filing
What does the Orange Book list for EMTRIVA manufacturing and labeling?
Answer: Not produced here because the prompt does not provide the EMTRIVA Orange Book entry identifiers needed to extract manufacturer/site-level detail.
What you normally extract from Orange Book for suppliers
- Application number (NDA)
- Dosage forms/strengths tied to each applicant/manufacturer
- Any listed “manufacturing use” changes for the finished product
Are there multiple EMTRIVA suppliers by dosage strength or formulation?
Answer: Not determinable from the prompt alone.
Key supplier fragmentation drivers
- Strength-specific manufacturing lines
- Packaging and labeling site differences
- Changes tied to FDA manufacturing supplements
How do generic or authorized supply chains affect EMTRIVA supplier mapping?
Answer: Not determinable from the prompt alone.
Generic/ANDA supply chain interactions
- Competitive products can pull additional supply capacity into the same API ecosystem
- Authorized suppliers can coexist with branded product sourcing, but brand API supplier identities still require DMF/site linkage
Which contract manufacturers support emtricitabine products?
Answer: Not determinable from the prompt alone.
Contract manufacturing footprints depend on
- Whether the query targets tablet vs oral solution vs capsules
- Whether it targets commercial supply vs clinical supply
- Whether it targets API vs fill-finish vs packaging
Key Takeaways
- EMTRIVA’s U.S. labeler/primary commercial source is Gilead Sciences, Inc.
- A complete supplier list (API manufacturers, finished-dose manufacturers by site, and alternate suppliers) cannot be produced accurately from the information provided.
- Supplier identification for emtricitabine typically requires Orange Book manufacturing details and/or DMF site mapping, neither of which is present in the prompt.
FAQs
- Who is the NDA holder/labeler for EMTRIVA (emtricitabine) in the U.S.?
- Does EMTRIVA use a single emtricitabine API source or multiple qualified API suppliers?
- How can I identify the finished-dose manufacturer sites for EMTRIVA by strength?
- Do EMTRIVA’s supplier sources change after manufacturing supplements to the FDA?
- How do DMFs and Orange Book manufacturing listings connect for emtricitabine API suppliers?
References (APA)
- Gilead Sciences, Inc. EMTRIVA (emtricitabine) product information and labeling (U.S.).
- FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. (EMTRIVA listing entry).
